Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 18, 2016Ondansetron Tablets USPFailed Impurities/Degradation Specifications; 12 month stability time pointDr. Reddy's Laboratories, Inc. · D-0841-2016Class IITerminatedMay 18, 2016Paliperidone Extended-release TabletsFailed Dissolution Specifications; three month stability time point.Mylan Pharmaceuticals Inc. · D-0840-2016Class IIITerminatedMay 11, 2016Acetaminophen & Codeine Phosphate TabletsLabeling: Not elsewhere classified - count on the label was incorrect.A-S Medication Solutions LLC. · D-0839-2016Class IITerminatedMay 11, 2016Oxycodone Hydrochloride Oral SolutionDefective Container: Excess lidding material accumulation between the seal and the cup resulting in the lid not properly adhering and allowing leakage.VistaPharm, Inc. · D-0838-2016Class IIITerminatedMay 11, 2016Venlafaxine 75 mg TabletLabeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate...Bryant Ranch Prepack Inc. · D-0837-2016Class IIIOngoingMay 11, 2016QuelicinLabeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.Hospira Inc. · D-0836-2016Class IITerminatedMay 11, 2016Good Neighbor Pharmacy PEG-Phen Lubricant Eye DropsPresence of Particulate MatterAkorn, Inc. · D-0835-2016Class IIITerminatedMay 4, 2016SKY Aspirin Chewable TabletsLabeling: Label mix-up -outer carton incorrectly labeled as aspirin chewable tablets.Mckesson Packaging Services · D-0834-2016Class IIITerminatedApr 27, 2016ZemplarFailed Content Uniformity SpecificationsAbbVie Inc. · D-0833-2016Class IITerminatedApr 27, 2016Potassium Chloride Injection 20 mEqChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0832-2016Class IITerminatedApr 27, 2016Mannitol I.VChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0831-2016Class IITerminatedApr 27, 2016Aminosyn-PFChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0830-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0829-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0828-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0827-2016Class IITerminatedApr 27, 2016Dextroamphetamine Sulfate Tablets USPFailed Impurities/Degradation SpecificationsImpax Laboratories, Inc. · D-0826-2016Class IITerminatedApr 27, 2016Dextroamphetamine Sulfate Tablets USPFailed Impurities/Degradation SpecificationsImpax Laboratories, Inc. · D-0825-2016Class IIITerminatedApr 27, 2016Telmisartan TabletsPresence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.Torrent Pharmaceuticals Limited · D-0824-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp DateAmerisource Health Services · D-0823-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp DateAmerisource Health Services · D-0822-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp. DateImpax Laboratories, Inc. · D-0821-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp. DateImpax Laboratories, Inc. · D-0820-2016Class IITerminatedApr 20, 2016Cisatracurium Besylate InjectionIncorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer...Fresenius Kabi USA, LLC · D-0819-2016Class IIITerminatedApr 20, 2016Haloperidol Decanoate InjectionFailed Impurities/Degradation Specifications: Firm is recalling product due to an impurity out-of-specification result.Fresenius Kabi USA, LLC · D-0818-2016Class IIITerminatedApr 20, 2016Simvastatin TabletsSubpotent DrugBiocon Inc · D-0817-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0816-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0815-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0814-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0813-2016Class IIITerminatedApr 13, 2016SODIUM IODIDE I 131 CAPSULELabeling: Label Error on Declared StrengthJubilant Draximage Inc · D-0812-2016Class IIITerminatedApr 13, 2016Minocycline Hydrochloride Capsules USPLabeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of...Apace KY LLC · D-0811-2016Class IIITerminatedApr 13, 2016IntermezzoFailed Dissolution SpecificationsPurdue Pharma L.P. · D-0810-2016Class IIITerminatedApr 13, 2016Ranitidine SyrupFailed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.Bio-pharm, Inc. · D-0809-2016Class IITerminatedApr 13, 2016Formula 2Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0808-2016Class IITerminatedApr 13, 2016Formula 0Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0807-2016Class IITerminatedApr 13, 2016Formula 3Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0806-2016Class IITerminatedApr 13, 2016Formula 1Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0805-2016Class IITerminatedApr 13, 2016Formula 9Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0804-2016Class IITerminatedApr 13, 2016Formula 4Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0803-2016Class IITerminatedApr 13, 2016Formula 2Superpotent Drug: one ingredient was found to be above assay specification.Meditech Laboratories, Inc · D-0802-2016